Hikma Pharmaceutical | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Almirall EUR 329.41M 15.11M 2024-06
AstraZeneca USD 5.49B 691M 2024-12
Bayer EUR 6.19B 1.57B 2024-12
Fresenius EUR 2.28B 788M 2024-12
Galapagos EUR 64.24M 8.72M 2024-12
Genmab DKK 9.86B 3.52B 2024-12
GlaxoSmithKline GBP 3.87B 678M 2024-12
GRIFOLS EUR 979.78M 334.84M 2024-12
Hikma Pharmaceutical USD 0 1000K 2024-06
Lonza CHF 1.11B 286M 2024-12
Merck EUR 2.15B 1.01B 2024-12
Orion EUR 205.6M 15.5M 2024-12
Recordati EUR 235.02M 34.44M 2024-09
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 6.8B 1.92B 2024-06
UCB EUR 1.57B 1.14B 2024-12



Hikma Pharmaceutical Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.